F066 So Many Biologics, So Little Time: How to Pick Your Poison in an Era of Biologic Overload
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
The biologic age has now fully encompassed dermatology with medicines available in numerous inflammatory skin diseases to provide the promise of efficacious, targeted treatments that are aligned to specific pathologic immune-mediated pathways. With 12 biologics in psoriasis, the advent of biosimilars, and numerous agents available or in late-stage development in other conditions such as atopic dermatitis, hidradenitis suppurativa, and vitiligo, this session will seek to clarify the place that biologics occupy in our treatment armamentariums for inflammatory skin conditions. Highlights will include challenging patient phenotypes and how to address them, and how to pick the ideal biologic for your patient.
LEARNING OBJECTIVES
Discuss the role of biologics in rationally targeting and treating inflammatory skin diseases, identifying optimal mechanisms in each clinical indication
Assess patient comorbidities, history, and treatment preferences to formulate treatment strategies with biologics
Develop therapeutic plans to treat challenging patients, such as those who have failed other therapies or have recalcitrant skin diseases
SCHEDULE
11:30 PM
"Why use Biologics and Biosimilars?" and Biologics for HS
George Han, MD, PhD, FAAD
11:45 PM
Biologics on the horizon for vitiligo
John Harris, MD, PhD, FAAD
12:00 AM
Considering Comorbidities in Psoriasis Patients
April W. Armstrong, MD, MPH, FAAD
12:15 AM
Putting Together Appropriate Therapeutic Ladders When Treating Psoriasis
Kenneth B. Gordon, MD, FAAD
12:30 AM
Integrating PsA into Your Psoriasis Discussion and Treatment Selection
Kristina Patrice Callis-Duffin, MD, FAAD
12:45 AM
Approaching the Challenging Psoriasis Patient
Bruce Elliot Strober, MD, PhD, FAAD
1:00 AM
Which biologic or no biologic? What would YOU do?
Sylvia Hsu, MD, FAAD
1:15 AM
Biologics for AD
Vivian Shi, MD, FAAD
SPEAKERS
April W. Armstrong, MD, MPH, FAAD
Kristina Patrice Callis-Duffin, MD, FAAD
Kenneth B. Gordon, MD, FAAD
George Han, MD, PhD, FAAD
John Harris, MD, PhD, FAAD
Sylvia Hsu, MD, FAAD
Vivian Shi, MD, FAAD
Bruce Elliot Strober, MD, PhD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
April W. Armstrong, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Consultant(Honoraria); Boehringer Ingelheim – Data Safety Monitoring Board(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding), Speaker(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma USA – Advisory Board(Honoraria); Incyte – Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Meiji – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Kristina Patrice Callis-Duffin, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Amgen – Advisory Board(Honoraria), Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Celgene Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
George Han, MD, PhD, FAAD
AbbVie – Speaker(Honoraria); Amgen – Advisory Board(Honoraria); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Advisory Board(Honoraria); Celgene – Investigator(Grants/Research Funding); DermTech Inc. – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Hikma Pharmaceuticals – Speaker/Faculty Education(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); MC2 Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Othro Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sonoma Pharmaceuticals – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); UCB – Advisory Board(Honoraria);
John Harris, MD, PhD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Aclaris Therapeutics, Inc. – Consultant(Fees); Aldena Therapeutics – Consultant(Fees), Founder(Stock); Almirall – Consultant(Fees); AnaptysBio – Consultant(Fees); Avita – Consultant(Fees); BiologicsMD, Inc. – Consultant(Honoraria); Celgene Corporation – Investigator(Grants/Research Funding); Dermavant Sciences – Consultant(Fees), Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Genzyme Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Granular Therapeutics – Consultant(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Klirna Biotech, Inc. – Founder(Stock); Klirna Therapeutics – Founder(Stock); Leo Pharma Inc – Investigator(Grants/Research Funding); Nira Biosciences, Inc. – Consultant(Fees), Founder(Stock); Pandion Therapeutics – Consultant(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Platelet BioGenesis, Inc. – Consultant(Fees); Rheos Medicines – Consultant(Honoraria), Investigator(Grants/Research Funding); Stiefel a GSK company – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); TeVido Biodevices, LLC – Advisory Board(Stock Options), Investigator(Grants/Research Funding), Stockholder(Stock); Villaris Therapeutics, Inc – Founder(Stock), Investigator(Grants/Research Funding); Vimela – Consultant(Honoraria), Stockholder(Stock); Vividion Therapeutics – Consultant (1099 relationship)(Fees);
Sylvia Hsu, MD, FAAD
argenx – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria); CoreEvitas, LLC – Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); OncLive State of the Science Summit – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);
Vivian Shi, MD, FAAD
AbbVie – Advisory Board(Fees), Speaker(Fees); Alumis – Advisory Board(Honoraria); Aristea Therapeutics – Advisory Board(Fees); Boehringer Ingelheim – Advisory Board(Fees); Burt's Bees – Consultant(Fees); Ceraclere – Consultant (1099 relationship)(Fees); Dematology Foundation – Other(Grants/Research Funding); Demira – Advisory Board(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees); Foundation of Atopic Dermatitis – Other(Grants/Research Funding); Galderma – Advisory Board(Fees); Genentech, Inc. – Advisory Board(Honoraria); Global Parents for Eczema Research – Consultant(No Compensation Received); GpSkin – Consultant(Fees); HS Foundation – Board of Directors(No Compensation Received); Incyte – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria); LearnHealth/LearnSkin – Other(Fees), Stockholder(Stock); Menlo Therapeutics – Advisory Board(Fees); National Eczema Association – Consultant (1099 relationship)(Honoraria), Speaker(No Compensation Received); Novartis – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Regeneron – Speaker(Fees); Sanofi Genzyme – Advisory Board(Fees), Speaker(Fees); Skin Actives Scientific – Other(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); UCB Pharma – Advisory Board(Honoraria);
Bruce Elliot Strober, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen-Ortho Inc. – Advisory Board(Honoraria), Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Union Therapeutics – Consultant(Fees);